The 11-Year-Old Girl Who Became Britain’s First Patient for a Sight-Saving Gene Therapy

For most of her childhood, one future appeared increasingly unavoidable. Her remaining vision was expected to fade gradually, leaving her family to prepare for a life shaped by near-total blindness.

Then an experimental procedure offered a possibility that had once seemed many years away. Its purpose is not to create perfect sight, but to protect what remains before the retinal damage becomes irreversible.